Nicotine pouches, oral cancer and tobacco harm reduction: current evidence and research priorities.
Level 5 - mechanism / opinion, no new human data
Narrative mini-review summarizing existing toxicology and clinical literature without systematic review methodology or new human data.
PubMed 41737135 · doi:10.3389/froh.2026.1761734
What was done
This narrative mini-review evaluated current evidence regarding the toxicological profile, oral mucosal effects, and oral cancer harm-reduction potential of tobacco-free oral nicotine pouches compared to combustible cigarettes and high-nitrosamine smokeless tobacco.
What was found
The abstract provides no numerical data. It notes that toxicological studies demonstrate significantly lower levels of harmful constituents relative to combustible cigarettes and traditional smokeless tobacco. Short-term clinical studies show reduced oral mucosal irritation and gingival inflammation in exclusive users. However, zero long-term epidemiological data are available to evaluate oral carcinogenesis.
Why it matters
Nicotine pouches could offer harm-reduction potential for adult users of combustible tobacco or high-risk smokeless tobacco products, but their oncologic safety profile cannot be confirmed without longitudinal evidence.
Limits
The review relies on existing literature without presenting new primary data. Human clinical studies to date are few, small, and heterogeneous, with no data evaluating long-term oral cancer outcomes, dual-use behaviors, or youth uptake.